SANT Committee prioritises manufacturing competitiveness in draft report on the Critical Medicines Act

‘Europe Has To Make Up Its Mind’ – Medicines For Europe’s Sieger On The Path Ahead

The president of Medicines for Europe talks about what the European healthcare sector needs and what the off-patent sector can deliver.

Read the comment of our President and full Article below.

Open

Medicines for Europe intervenes in legal challenge against Urban Wastewater Treatment Directive’s EPR scheme

European Industry Calls For Support As It Juggles Multiple Challenges

At Medicines for Europe’s Legal and Annual Conferences in Brussels last week, multiple key issues were discussed to support the role of generics and biosimilars at a critical time for EU pharma reform.

Read the comment of our President and full Article below.

Open

Pro-competitive policies matter for public health, for security and for strategic autonomy

Pharma reform should provide for more timely patient access in Europe

Medicines for Europe outlines trade policy recommendations to strengthen access to medicines and the competitiveness of EU manufacturing

Markus Sieger takes the helm as President ad interim at Medicines for Europe

Council agreement on review of EU pharmaceutical legislation

Medicines for Europe calls for balanced safeguards on access to medicines in EU Water Resilience Strategy